Skip to search formSkip to main contentSkip to account menu

sivelestat

Known as: Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-, N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice. I ntroduction… 
2012
2012
BackgroundThe effects of sivelestat on endotoxin-induced lung injury, postperfusion lung injury, and ischemia–reperfusion are… 
2011
2011
We developed a neutrophil elastase-specific near-infrared fluorescence imaging agent, which, combined with fluorescence molecular… 
2011
2011
BackgroundRecent evidence has indicated that sivelestat, a neutrophil elastase inhibitor, has liver-protective effects in a… 
2010
2010
BACKGROUND Sivelestat, a neutrophil elastase inhibitor, has been used to treat acute lung injury (ALI) with varying levels of… 
2006
2006
PurposeWe assessed the effects of a neutrophil elastase inhibitor, sivelestat, on respiratory and organ functions as well as on… 
2006
2006
Abstract:  Treatment with all‐trans retinoic acid (ATRA) improves the prognosis of patients with acute promyelocytic leukemia… 
2005
2005
Objective:The purpose of this study was to evaluate the effect of a neutrophil elastase inhibitor, sivelestat, on… 
2005
2005
The underlying mechanism involved in the interaction between neutrophil elastase inhibitors and tachykinins has not been…